One year after declaring a state of emergency in California due to COVID-19, the California Governor issued a new Executive Order lifting pricing restrictions on most categories of products previously subject to California’s price gouging statute. Governor Gavin Newsom’s 2021 Order comes as states across the nation slowly reopen. This 2021 Executive Order marks a change for businesses in California.

 Extending the State of Emergency

On March 3, 2020, Governor Newsom proclaimed a state of emergency in California, triggering the state’s price gouging statute. The 2020 Executive Order detailed four categories of goods to which the pricing restrictions applied: food items, consumer goods, medical or emergency supplies, and designated “scarce materials” under the Defense Production Act. The California Penal Code prohibits selling, or offering for sale, covered products at a price more than 10% greater than the price offered for that good in the 30 days prior to the declaration of an emergency.

As the 2020 Executive Order was slated to expire on March 4, 2021, it comes as no surprise that Governor Newsom issued a revised Executive Order on March 4, 2021. However, the Governor did not merely extend the status quo. Instead, Governor Newsom chose to extend the scope of the emergency declaration to fewer product categories. Under the terms of the 2021 Executive Order, the California price gouging statute continues to apply, but only as to medical supplies and emergency supplies. Under the 2021 Executive Order, price gouging prohibitions no longer apply to other categories, including food and consumer goods.

Medical and Emergency Supplies

According to the statute, emergency supplies include items such as water, blankets, soaps, diapers, and toiletries.  Medical supplies include “prescription and nonprescription medications, bandages, gauze, isopropyl alcohol, and antibacterial products.” The law provides that the goods listed are merely examples, not a comprehensive inventory.

Despite lifting the price gouging restrictions for most products in California, the 2021 Executive Order is not the end of the story for businesses. The price gouging statute continues to apply to a variety of products related to the COVID-19 emergency. Business should continue to monitor the types of products that could be considered “emergency or medical supplies.” The statutory list is not exhaustive and COVID specific items will likely remain covered under the statute for some time.

Why Lift the Restrictions and What’s Next?

The Governor’s 2021 Executive Order provides several justifications for lifting the blanket emergency declaration that has been force for a full year.  According to Governor Newsom, the protections are no longer necessary “to ensure Californians’ access to many necessary goods and services.”  Instead, the Governor believes that a variety of mechanisms are sufficient to achieve the purposes underlying the statute.

During the 2019-2020 legislative session, the California Legislature amended the price gouging statute: (1) allowing the Governor to designate the applicable date of the pricing restrictions, (2) allowing the Governor to extend the duration of the prohibitions, and (3) creating a new restriction, prohibiting sellers from charging a price more than 50% of the sellers cost if the seller did not market the product before the state of emergency.  According to the Governor, the Legislature’s “intent to protect residents from price gouging during states of emergency” and its recent statutory amendments provided the latitude for the 2021 Executive Order.

Looking forward, businesses should continue to monitor the COVID related products that could be construed as “emergency” supplies.  While many of the California pricing restrictions have been lifted by the 2021 Executive Order, the Governor was clear that should circumstances change, these restrictions may be put back into effect.

Finally, the California statute provides for a 4 year statute of limitations for bringing price gouging complaints.  Businesses should continue to use best practices to evaluate the risk of a price gouging suit as price changes over the past year could continue to invoke scrutiny.

*      *      *

Visit Proskauer on Price Gouging for antitrust insights on COVID-19.

*      *      *

Proskauer’s cross-disciplinary, cross-jurisdictional Coronavirus Response Team is focused on supporting and addressing client concerns. Visit our Coronavirus Resource Center for guidance on risk management measures, practical steps businesses can take and resources to help manage ongoing operations.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Christopher E. Ondeck Christopher E. Ondeck

Chris Ondeck is co-chair of the Firm’s Antitrust Group and co-head of the Washington DC office. He represents clients in complex antitrust and consumer protection litigation, defends mergers and acquisitions before the U.S. antitrust agencies, represents companies involved in government investigations, and counsels…

Chris Ondeck is co-chair of the Firm’s Antitrust Group and co-head of the Washington DC office. He represents clients in complex antitrust and consumer protection litigation, defends mergers and acquisitions before the U.S. antitrust agencies, represents companies involved in government investigations, and counsels on antitrust compliance. Chris is also the founder and leader of the firm’s Price Gouging Practice, and is one of the key thought leaders in this space.

Chris handles antitrust matters for clients in a number of industries, including food and agriculture, financial services, media, telecom, technology, e-commerce, consumer products, natural resources, oil and gas, chemicals, and pharmaceuticals.  He also serves as outside counsel to a large number of industry groups, including trade associations and cooperatives.

Chris has been recognized as a leading antitrust practitioner by Chambers, noting that clients describe him as “our primary thought partner – he’s very good at explaining the complex issues and making them easy to understand” and praising “his strong advocacy skills”; by The National Law Review as a “Go To Thought Leader 2020”; by Acritas as a “Star” in multiple years; by Benchmark Litigation as a National Litigation Star 2021; and by The Legal 500 United States for Antitrust: Civil Litigation/Class Actions.

Photo of John R. Ingrassia John R. Ingrassia

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating…

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.

For more than 25 years, John has counselled businesses facing the most challenging antitrust issues and helped them stay out of the crosshairs — whether its distribution, pricing, channel management, mergers, acquisitions, joint ventures, or price gouging compliance.

John’s practice focuses on the analysis and resolution of CFIUS and antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger CFIUS and HSR notification requirements. He advises clients on issues related to CFIUS national security reviews, and on CFIUS submissions when non-U.S. buyers seek to acquire U.S. businesses that have national security sensitivities.  He also regularly advises clients on international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes.

His knowledge, reputation and extensive experience with the legal, practical, and technical requirements of merger clearance make him a recognized authority on Hart-Scott-Rodino antitrust merger review. John is regularly invited to participate in Federal Trade Commission and bar association meetings and takes on the issues of the day.

Photo of Shannon D. McGowan Shannon D. McGowan

Shannon McGowan is an associate in the Litigation department.  Shannon’s practice focuses on assisting clients navigate a range of antitrust issues.  In addition to her experience on wide-ranging antitrust litigations, Shannon works with clients on general antitrust compliance and litigation issues.  In connection…

Shannon McGowan is an associate in the Litigation department.  Shannon’s practice focuses on assisting clients navigate a range of antitrust issues.  In addition to her experience on wide-ranging antitrust litigations, Shannon works with clients on general antitrust compliance and litigation issues.  In connection with historic restructuring of Puerto Rico’s debts, Shannon advises the Financial Oversight and Management Board for Puerto Rico on a variety of issues related to Puerto Rico Oversight, Management, and Economic Stability Act.

Shannon maintains an active pro bono practice, including assisting non-profit organizations with research into immigration and refugee law and representing individual clients in litigation to improve housing conditions in the Washington D.C. area.

Shannon earned her J.D. from the University of Virginia School of Law, where she captained the school’s Philip C. Jessup International Law Moot Court team.  As an alumnae, she is active in advising the current UVA Jessup Team throughout the year-long competition.

Prior to law school, Shannon served as a legislative assistant to state representatives at the Oklahoma State House of Representatives, where she researched and advised on legislation and policy issues, including government transparency, education, and financial accountability.